Table 1 Baseline characteristics of CHB-related compensated cirrhosis
TDF-containing | Non-TDF-containing | p-value | |
|---|---|---|---|
(n = 127) | (n = 115) | ||
Age, (mean ± SD) | 50 ± 12 | 50 ± 10 | 0.62 |
Gender | 0.28 | ||
Male | 114 (89.8%) | 98 (85.2%) | |
Female | 13 (12.4%) | 17 (9.7%) | |
HBV DNA (log10 copy/mL, mean ± SD) | 3.93 ± 1.31 | 3.88 ± 1.18 | 0.76 |
HBeAg | 0.92 | ||
Positive | 92 (72.4%) | 84 (73.0%) | |
Negative | 35 (27.6%) | 31 (27.0%) | |
ALT (U/L, mean ± SD) | 98.3 ± 23.6 | 96.3 ± 24.4 | 0.34 |
Total bilirubin (μmol/L), median (range) | 16.1 (5.7–65.0) | 14.4 (5.5–39.8) | 0.11 |
ALB (g/L), median (range) | 4.1 (3.7–5.9) | 4.0 (2.8–6.0) | 0.19 |
AFP, ng/mL, median (range) | 2.91 (1.21–34) | 3.11 (1.36–21) | 0.06 |
PLT, 10^9/L, median (range) | 197.33 (99–252) | 184.31 (108–239) | 0.08 |
Child-Pugh score | 0.87 | ||
A | 122 (96.1%) | 110 (95.6%) | |
B | 5 (3.9%) | 5 (4.4%) |